Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per thor Straten

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Human Immunology|May 20, 2008
Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patientsPia Kvistborg, Sine Reker Hadrup, Inge Marie Svane, et al.
Cancers|April 3, 2021
TAM Receptor Inhibition-Implications for Cancer and the Immune SystemPia Aehnlich, Richard Morgan Powell, Marlies J W Peeters, et al.
Cancers|January 26, 2021
Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?Agnete Witness Praest Jensen, Ana Micaela Carnaz Simões, Per Thor Straten, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccinationJon Amund Kyte, Sissel Trachsel, Bente Risberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodesHenrik Søndergaard, Elisabeth D Galsgaard, Monica Bartholomaeussen, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2008
RhoC a new target for therapeutic vaccination against metastatic cancerLynn Wenandy, Rikke Baek Sørensen, Inge Marie Svane, et al.
Cells|April 9, 2014
Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using ElispotStine Kiaer Larsen, Morten Hansen, Inge Marie Svane, et al.
Cancer Research|December 3, 2005
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and BSøren Skov, Marianne Terndrup Pedersen, Lars Andresen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
Cytokine fusion protein treatmentDavid Schrama, Per thor Straten, Eva-Bettina Bröcker, et al.
Frontiers in Immunology|September 28, 2020
Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-betPia Aehnlich, Ana Micaela Carnaz Simões, Signe Koggersbøl Skadborg, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Human Immunology|May 20, 2008
Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patientsPia Kvistborg, Sine Reker Hadrup, Inge Marie Svane, et al.
Cancers|April 3, 2021
TAM Receptor Inhibition-Implications for Cancer and the Immune SystemPia Aehnlich, Richard Morgan Powell, Marlies J W Peeters, et al.
Cancers|January 26, 2021
Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?Agnete Witness Praest Jensen, Ana Micaela Carnaz Simões, Per Thor Straten, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccinationJon Amund Kyte, Sissel Trachsel, Bente Risberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodesHenrik Søndergaard, Elisabeth D Galsgaard, Monica Bartholomaeussen, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2008
RhoC a new target for therapeutic vaccination against metastatic cancerLynn Wenandy, Rikke Baek Sørensen, Inge Marie Svane, et al.
Cells|April 9, 2014
Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using ElispotStine Kiaer Larsen, Morten Hansen, Inge Marie Svane, et al.
Cancer Research|December 3, 2005
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and BSøren Skov, Marianne Terndrup Pedersen, Lars Andresen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
Cytokine fusion protein treatmentDavid Schrama, Per thor Straten, Eva-Bettina Bröcker, et al.
Frontiers in Immunology|September 28, 2020
Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-betPia Aehnlich, Ana Micaela Carnaz Simões, Signe Koggersbøl Skadborg, et al.
Pageof 16